Induction Chemoradiotherapy Followed by Surgical Resection for Clinical T3 or T4 Locally Advanced Non–Small Cell Lung Cancer

[1]  J. Sculier Nonsmall cell lung cancer , 2013, European Respiratory Review.

[2]  K. Kerr,et al.  Guidelines on the radical management of patients with lung cancer , 2010, Thorax.

[3]  Keitaro Matsuo,et al.  Phase III trial comparing docetaxel and cisplatin combination chemotherapy with mitomycin, vindesine, and cisplatin combination chemotherapy with concurrent thoracic radiotherapy in locally advanced non-small-cell lung cancer: OLCSG 0007. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  D. Mannino COPD as a disease of children: hype or hope for better understanding? , 2010, Thorax.

[5]  R. Mirimanoff,et al.  Neoadjuvant chemotherapy and radiotherapy followed by surgery in selected patients with stage IIIB non-small-cell lung cancer: a multicentre phase II trial. , 2009, The Lancet. Oncology.

[6]  V. Rusch,et al.  Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial , 2009, The Lancet.

[7]  J. Jett,et al.  Treatment of non-small cell lung cancer, stage IIIB: ACCP evidence-based clinical practice guidelines (2nd edition). , 2007, Chest.

[8]  C. Stevens,et al.  Treatment of non-small cell lung cancer-stage IIIA: ACCP evidence-based clinical practice guidelines (2nd edition). , 2007, Chest.

[9]  J. Crowley,et al.  The IASLC Lung Cancer Staging Project: Proposals for the Revision of the TNM Stage Groupings in the Forthcoming (Seventh) Edition of the TNM Classification of Malignant Tumours , 2007, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[10]  T. Okamoto,et al.  Induction chemoradiotherapy (carboplatin-taxane and concurrent 50-Gy radiation) for bulky cN2, N3 non-small cell lung cancer. , 2007, The Journal of thoracic and cardiovascular surgery.

[11]  V. Rusch,et al.  Induction chemoradiation and surgical resection for superior sulcus non-small-cell lung carcinomas: long-term results of Southwest Oncology Group Trial 9416 (Intergroup Trial 0160). , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  Quynh-Thu Le,et al.  Non-small cell lung cancer: Clinical practice guidelines in oncology , 2006 .

[13]  L. Voltolini,et al.  Lung cancer with chest wall involvement: predictive factors of long-term survival after surgical resection. , 2006, Lung cancer.

[14]  D. Wood,et al.  Surgical Management of T3 and T4 Lung Cancer , 2005, Clinical Cancer Research.

[15]  Y. Nishiwaki,et al.  Visceral pleural invasion is an invasive and aggressive indicator of non-small cell lung cancer. , 2005, The Journal of thoracic and cardiovascular surgery.

[16]  K. Kiura,et al.  Preoperative concurrent chemoradiotherapy with cisplatin and docetaxel in patients with locally advanced non-small-cell lung cancer , 2004, British Journal of Cancer.

[17]  K. Eguchi,et al.  Phase I/II study of docetaxel and cisplatin with concurrent thoracic radiation therapy for locally advanced non-small-cell lung cancer , 2003, British Journal of Cancer.

[18]  P. Yildiz,et al.  Comparison of clinical and surgical-pathologic staging of the patients with non-small cell lung carcinoma. , 2002, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[19]  K. Kiura,et al.  Preoperative induction chemotherapy with cisplatin and irinotecan for pathological N2 non-small cell lung cancer , 2002, British Journal of Cancer.

[20]  P. Dartevelle,et al.  Factors affecting long-term survival after en-bloc resection of lung cancer invading the chest wall. , 2000, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[21]  V. Rusch,et al.  Extent of chest wall invasion and survival in patients with lung cancer. , 1999, The Annals of thoracic surgery.

[22]  E. McFadden,et al.  Toxicity and response criteria of the Eastern Cooperative Oncology Group , 1982, American journal of clinical oncology.

[23]  B. Yalcin,et al.  Multidisciplinary management of lung cancer. , 2004, The New England journal of medicine.